MALE5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
__TOC__ | |||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big> | |+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big> | ||
| Line 17: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|CHAPTER 2 (TUMOURS OF THE KIDNEY) | | | ||
==== CHAPTER 2 (TUMOURS OF THE KIDNEY) ==== | |||
| | | | ||
---- | ---- | ||
| Line 466: | Line 469: | ||
| | | | ||
|- | |- | ||
|CHAPTER 3 (TUMOURS OF THE URINARY TRACT) | | | ||
==== CHAPTER 3 (TUMOURS OF THE URINARY TRACT) ==== | |||
| | | | ||
---- | ---- | ||
| Line 695: | Line 699: | ||
| | | | ||
|- | |- | ||
|CHAPTER 4 (TUMOURS OF THE PROSTATE) | | | ||
==== CHAPTER 4 (TUMOURS OF THE PROSTATE) ==== | |||
| | | | ||
---- | ---- | ||
| Line 836: | Line 841: | ||
| | | | ||
|- | |- | ||
|CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) | | | ||
==== CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) ==== | |||
| | | | ||
---- | ---- | ||
| Line 900: | Line 906: | ||
| | | | ||
|- | |- | ||
|CHAPTER | | | ||
==== CHAPTER 6 (TUMOURS OF THE TESTIS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,239: | Line 1,246: | ||
| | | | ||
|- | |- | ||
|CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) | | | ||
==== CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,468: | Line 1,476: | ||
| | | | ||
|- | |- | ||
|CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) | | | ||
==== CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,587: | Line 1,596: | ||
| | | | ||
|- | |- | ||
|CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) | | | ||
==== CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,662: | Line 1,672: | ||
| | | | ||
|- | |- | ||
|CHAPTER 10 (MESENCHYMAL TUMOURS) | | | ||
==== CHAPTER 10 (MESENCHYMAL TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,847: | Line 1,858: | ||
| | | | ||
|- | |- | ||
|CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) | | | ||
==== CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,911: | Line 1,923: | ||
| | | | ||
|- | |- | ||
|CHAPTER 12 (MELANOCYTIC LESIONS) | | | ||
==== CHAPTER 12 (MELANOCYTIC LESIONS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,942: | Line 1,955: | ||
| | | | ||
|- | |- | ||
|CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) | | | ||
==== CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,995: | Line 2,009: | ||
| | | | ||
|- | |- | ||
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) | | | ||
==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 2,105: | Line 2,120: | ||
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]] | |[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
|- | |- | ||
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]] | |[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]] | ||